Secondary Logo

Journal Logo


Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca

A Pooled Analysis of Phase 2b/3 and Phase 3 Studies


doi: 10.1097/ICO.0000000000002221
  • Free

In the October 2019 issue of Cornea, one of the co-author's degrees was incorrect in the article on pages 1259–1265.1 Jodi Luchs, OD, should instead be listed as Jodi Luchs, MD.


1. Malhotra R, Devries DK, Luchs J, et al. Effect of OTX-101, a novel nanomicellar formulation of cyclosporine A, on corneal staining in patients with keratoconjunctivitis sicca: a pooled analysis of phase 2b/3 and phase 3 studies. Cornea. 2019;38:1259–1265.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.